The Molecular Basis of Lung Carcinogenesis

作者: Kwun M. Fong , Yoshitaka Sekido , John D. Minna

DOI: 10.1007/978-1-59259-125-1_17

关键词:

摘要: Lung cancer is the leading cause of deaths in Western world. According to World Health Organization (WHO), lung kills about 1 million people worldwide each year. United States 1997, accounted for 13% new cases, and 32% males 17% females (1).

参考文章(348)
Jerzy K. Kulski, Theodora Demeter, Slavko Mutavdzic, Gregory F. Sterrett, Kenneth M. Mitchell, Ellis C. Pixley, Survey of histologic specimens of human cancer for human papillomavirus types 6/11/16/18 by filter in situ hybridization. American Journal of Clinical Pathology. ,vol. 94, pp. 566- 570 ,(1990) , 10.1093/AJCP/94.5.566
P. Rabbitts, R. Rudd, G. Sinha, P. Hasleton, P. Ganly, N. M. Bleehen, V. Sundaresan, p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus Oncogene. ,vol. 7, pp. 1989- 1997 ,(1992)
Fishback N, Przygodzki Rm, Guinee Dg, Bakker A, Finkelstein Sd, Koss M, Travis Wd, Swalsky Pa, Langer Jc, Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. American Journal of Pathology. ,vol. 148, pp. 1531- 1541 ,(1996)
L. M. Weiss, Zhi-Hua Li, D. Shibata, Jian Zheng, c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung. American Journal of Pathology. ,vol. 144, pp. 303- 309 ,(1994)
Piantadosi S, Figlin Ra, Holmes Ec, Koga H, Reissmann Pt, Takahashi R, Slamon Dj, Cordon-Cardo C, Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer Oncogene. ,vol. 8, pp. 1913- 1919 ,(1993)
Y. Ebihara, H. Kato, B. Franzén, G. Auer, T. Hirano, Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression. American Journal of Pathology. ,vol. 144, pp. 296- 302 ,(1994)
S. N. Khleif, F. J. Kaye, Weidong Chen, A. B. Coxon, G. A. Otterson, CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2'deoxycytidine. Oncogene. ,vol. 11, pp. 1211- 1216 ,(1995)
A. F. Gazdar, J. R. Gnarra, W. M. Linehan, B. Zbar, Farida Latif, M. I. Lerman, Y. Sekido, J. D. Minna, S. Bader, Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines. Oncogene. ,vol. 9, pp. 1599- 1604 ,(1994)
Karlan B, Plummer Sj, Casey G, Ramos Jc, Shaughnessy M, Lopez Me, Arboleda Mj, Slamon Dj, DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene. ,vol. 13, pp. 1971- 1981 ,(1996)
R. Rosell, J. Maestre, A. Ariza, A. Barnadas, M. Canela, E. Tolosa, J. L. Mate, P. Armengol, Z. Skacel, Shanrong Li, Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients. Oncogene. ,vol. 8, pp. 2407- 2412 ,(1993)